Jumin Park1, Leslie Wehrlen1, Sandra A Mitchell2, Li Yang1, Margaret F Bevans3. 1. National Institutes of Health Clinical Center, 10 Center Drive, Bethesda, MD, 20892-1151, USA. 2. National Cancer Institute, Division of Cancer Control and Population Sciences, Outcomes Research Branch, Rockville, MD, USA. 3. National Institutes of Health Clinical Center, 10 Center Drive, Bethesda, MD, 20892-1151, USA. Margaret.Bevans@nih.gov.
Abstract
PURPOSE: The aim of this study is to examine social adjustment to illness and to identify factors related to social adjustment in allogeneic hematopoietic cell transplantation (HCT) survivors. METHODS: Cross-sectional data were drawn from a longitudinal study of patients ≥ 3 years after their first HCT. The five subscales of the Psychosocial Adjustment to Illness Scale (PAIS) that reflect social adjustment, specifically vocational environment (VE); domestic environment (DE); sexual relationships (SEX); extended family relationships (ER); and social environment (SE) were examined in this analysis. Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) measured cancer-related fatigue. RESULTS: Subjects (N = 171) were a median of 5.19 years from HCT (range 3-16). The most impaired dimension of social adjustment was ER with 38% of participants reaching clinically relevant (score ≥ 62) levels of social maladjustment. Unmarried and unemployed participants had lower levels of social adjustment in VE (p < .001 and p < .001, respectively) and DE (p = .004 and p = .006, respectively). Survivors with some college had poorer SEX adjustment than those with less or more education (p < .005). Hispanics reported lower adjustment with respect to ER adjustment (p = .002). Participants with higher fatigue had poorer adjustment in all five dimensions (p < .001). CONCLUSIONS: Although the majority of survivors are well adjusted, subgroups may experience significant poor social adjustment. Specifically, survivors with fatigue are at risk to experience lower levels of social adjustment. Development of effective rehabilitation strategies to improve affected areas of social health is warranted, and all HCT survivors should be screened periodically for social maladjustment and provided with resources and referrals.
PURPOSE: The aim of this study is to examine social adjustment to illness and to identify factors related to social adjustment in allogeneic hematopoietic cell transplantation (HCT) survivors. METHODS: Cross-sectional data were drawn from a longitudinal study of patients ≥ 3 years after their first HCT. The five subscales of the Psychosocial Adjustment to Illness Scale (PAIS) that reflect social adjustment, specifically vocational environment (VE); domestic environment (DE); sexual relationships (SEX); extended family relationships (ER); and social environment (SE) were examined in this analysis. Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) measured cancer-related fatigue. RESULTS: Subjects (N = 171) were a median of 5.19 years from HCT (range 3-16). The most impaired dimension of social adjustment was ER with 38% of participants reaching clinically relevant (score ≥ 62) levels of social maladjustment. Unmarried and unemployed participants had lower levels of social adjustment in VE (p < .001 and p < .001, respectively) and DE (p = .004 and p = .006, respectively). Survivors with some college had poorer SEX adjustment than those with less or more education (p < .005). Hispanics reported lower adjustment with respect to ER adjustment (p = .002). Participants with higher fatigue had poorer adjustment in all five dimensions (p < .001). CONCLUSIONS: Although the majority of survivors are well adjusted, subgroups may experience significant poor social adjustment. Specifically, survivors with fatigue are at risk to experience lower levels of social adjustment. Development of effective rehabilitation strategies to improve affected areas of social health is warranted, and all HCT survivors should be screened periodically for social maladjustment and provided with resources and referrals.
Entities:
Keywords:
Cancer survivors; Fatigue; Hematopoietic stem cell transplantation; Social adjustment
Authors: S Bieri; E Roosnek; C Helg; F Verholen; D Robert; B Chapuis; J Passweg; R Miralbell; Y Chalandon Journal: Bone Marrow Transplant Date: 2008-08-18 Impact factor: 5.483
Authors: Shahrukh K Hashmi; Alok Srivastava; Walid Rasheed; Salman Adil; Tong Wu; Madan Jagasia; Amr Nassar; William Y K Hwang; Amir Ali Hamidieh; Hildegard T Greinix; Marcelo C Pasquini; Jane F Apperley; Mahmoud Aljurf Journal: Hematol Oncol Stem Cell Ther Date: 2017-07-14
Authors: Christine N Duncan; Navneet S Majhail; Ruta Brazauskas; Zhiwei Wang; Jean-Yves Cahn; Haydar A Frangoul; Robert J Hayashi; Jack W Hsu; Rammurti T Kamble; Kimberly A Kasow; Nandita Khera; Hillard M Lazarus; Alison W Loren; David I Marks; Richard T Maziarz; Paulette Mehta; Kasiani C Myers; Maxim Norkin; Joseph A Pidala; David L Porter; Vijay Reddy; Wael Saber; Bipin N Savani; Harry C Schouten; Amir Steinberg; Donna A Wall; Anne B Warwick; William A Wood; Lolie C Yu; David A Jacobsohn; Mohamed L Sorror Journal: Biol Blood Marrow Transplant Date: 2014-10-12 Impact factor: 5.742
Authors: Margaret F Bevans; Sandra A Mitchell; John A Barrett; Michael R Bishop; Richard Childs; Daniel Fowler; Michael Krumlauf; Patricia Prince; Nonniekaye Shelburne; Leslie Wehrlen; Li Yang Journal: Biol Blood Marrow Transplant Date: 2013-12-17 Impact factor: 5.742
Authors: P Esser; K Kuba; A Mehnert; A Schwinn; L Schirmer; F Schulz-Kindermann; M Kruse; U Koch; A R Zander; N Kröger; G Schilling; H Götze; A Scherwath Journal: Bone Marrow Transplant Date: 2017-01-23 Impact factor: 5.483
Authors: A Im; S A Mitchell; S M Steinberg; L Curtis; A Berger; K Baird; Z Kuzmina; G Joe; L E Comis; M Juckett; D Avila; J Baruffaldi; L Masuch; F Pirsl; S Z Pavletic Journal: Bone Marrow Transplant Date: 2016-02-01 Impact factor: 5.483
Authors: Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786
Authors: Yvonne H Sada; Olia Poursina; He Zhou; Biruh T Workeneh; Sandhya V Maddali; Bijan Najafi Journal: PLoS One Date: 2021-02-26 Impact factor: 3.240
Authors: Sencer Goklemez; Leorey N Saligan; Filip Pirsl; Noa G Holtzman; Alen Ostojic; Seth M Steinberg; Frances T Hakim; Jeremy J Rose; Zhigang Kang; Yunkai Yu; Liang Cao; Sandra A Mitchell; Annie Im; Steven Z Pavletic Journal: Bone Marrow Transplant Date: 2021-08-25 Impact factor: 5.483
Authors: Julia Spierings; Carolijn Jm de Bresser; Femke Cc van Rhijn-Brouwer; Arwen Pieterse; Madelon C Vonk; Alexandre E Voskuyl; Jeska K de Vries-Bouwstra; Jacob M van Laar; Marijke C Kars Journal: J Scleroderma Relat Disord Date: 2020-05-28